Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 3 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 442INDUSTRY 82NIH 40NETWORK 35OTHER_GOV 19UNKNOWN 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1

Conditions

Stomach Neoplasms 1Small Cell Lung Carcinoma 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1

Interventions

S 1 (combination) 12Capecitabine 11Paclitaxel 9Cisplatin 9apatinib 8Oxaliplatin 8pyrotinib 6nimotuzumab 6130-nm albumin-bound paclitaxel 6titanium silicide 5sintilimab 5camrelizumab 5anlotinib 5Etoposide 5Docetaxel 5Carboplatin 5Trastuzumab 4Radiotherapy, Intensity-Modulated 4Irinotecan 4Bevacizumab 4Albumin-Bound Paclitaxel 4nedaplatin 3Vinorelbine 3Temozolomide 3Tegafur 3Taxes 3Radiosurgery 3Gemcitabine 3Fluorouracil 3Epirubicin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × Irinotecan × Clear all
NCT04247984 2022-03-11

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

ChineseAMS

Phase 2 Completed
264 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03603756 2020-02-11

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

ChineseAMS

Phase 2 Unknown
45 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02323737 2014-12-30

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

ChineseAMS

Phase 2 Completed
62 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01444521 2014-05-06

Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer

ChineseAMS

Phase 2 Completed
50 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡